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1. Introduction 
Multimodality neuromonitoring has became increasingly complex, and although advances 
in neuromonitoring have provided insight into pathophysiology and physiological response 
to therapy, beneficial effects on patient outcomes have not been definitively established. The 
attitude towards the benefits of monitoring equipment has often been guided by wishful 
thinking. Rosner and colleague (Rosner MJ,1986) popularized the notion that cerebral 
perfusion pressure (CPP) should be aggressively managed at levels above 70-90 mmHg, if 
necessary by using vasopressors. At the same time, however, the “Lund concept” urged for 
a reduction of microvascular hydrostatic pressures to minimize oedema formation, 
accepting CPP as low as 50 mmHg in adults (Grände PO,2002 ). Following an update of the 
Brain Trauma Foundation guidelines in 2003, the consensus target value for CPP has been 
set at 60 mmHg. Even so, the controversy described above exemplifies the frustrating lack of 
good evidence that is available to make rational treatment decisions in the setting of 
intracranial pressure (ICP)-guide care. It is important to consider that there is large 
heterogeneity within the head trauma population, the intracerebral hemorrhage, the 
subarachnoid hemorrhage and the physiopathology between them. Therefore it is possible 
that many commonly used interventions that are aimed to reduce intracranial hypertension 
are ineffective, unnecessary or even harmful for some patient at certain times, at certain 
values. There is an increasing awareness that an aggressive ICP and CPP targeted approach 
may result in cardiorespiratory complications. A key limitation in the demonstration of 
efficacy of monitoring in neurocritical care is the complexity of care generated by 
multimodality monitoring. If one considers continuously monitoring 10-20 interrelated 
physiological parameters in a modern neurocritical care unit and each parameter has 10 
possible interventions, the enormous potential number of co-interventions represents a 
formidable challenge in clinical trial design. The application of continuous 
neurophysiological monitoring with somatosensory evoked potential (SEP) and 
electroencephalography (EEG) have an intuitive appeal, since these techniques yeald a 
direct measure of brain function in patients whose neurological status might otherwise be 
difficult to evaluate. The early components of SEP are used in the acute phase of cerebral 
damage when the patient, as result of sedatives, neuromuscular blockade or the severity of 
coma, is difficult to assess on a clinical level. Short latency SEP are largely resistant to 
analgo-sedation and have a waveform, which is easily interpretable and comparable in 
subsequent recordings. They have peripheral, spinal, brainstem and intracortical 
components, which are identifiable in all subject exploring an extended Cerebral Nervous 
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System (CNS) pathway. In the absence of a relevant lesion along afferent sensory pathways, 
a “global” index of brain function (reflected of brainstem, thalamo-cortical and intracortical 
transmission in both emispheres) can be extrapolated from them. The concept of secondary 
insults occurring after the primary neurologic injury was put forth by Jennet and colleagues 
(Rose et al., 1977), Andrew et al. (1990) and later by Miller et al. (1994), who reported that 
the majority of patients (91%) suffered secondary insults. The secondary insults that 
occurred most frequently were raised intracranial pressure, hypotension, and pyrexia. 
Moreover, several investigator have reported ongoing transient and dynamic changes in 
brain metabolism and neurochemistry (Bullock et al., 1995; Vespa et al., 2003) after brain 
injury. Continuous EEG monitoring is a valuable clinical instrument “to detect and protect”; 
to detect seizures and protect the brain from seizures-related injury in critically ill patients, 
whose brain are often in a particular vulnerable state. 
2. The Importance of the aetiology of coma 
2.1 Anoxic coma 
The prognostic value of SEP patterns in anoxia is complex 
Preserved short or middle-latency SEP do not prognosticate awakening with sufficient 
certainty,but absent cortical SEP are among the most powerful predictors of non-awakening 
from anoxic coma. 
The bilateral absence of N20 in anoxic coma (and only in anoxic coma) is a very reliable 
indicator of poor prognosis,since none of the patients reported in literature did better than 
PVS. Therefore ,this pattern provides strong information for decision making in intensive 
care . 
2.2 Head trauma 
Can be associated with both “primary” and “secondary” dysfunction. 
Primary dysfunction can be a consequence of mechanical lesions,which are usually 
irreversible,of associated brain oedema,which may be reversible. Mechanical lesions can 
consist either of brain contusion or diffuse axonal lesions (white matter of the cerebral 
hemispheree, corpus callosum,midbrain). 
Secondary dysfunction may be ischemic (systemic hypoperfusion),epileptic, or due to 
intracranial hypertension and its complications (transtenorial herniation,brain death). 
Short latency SEP are normal in about 50% of cases. Moreover, in contrast with brain anoxia, 
in which it has no prognostic meaning,the observation of bilaterally normal short-latency 
SEP constitutes a favourable sign in head trauma (predictive positive value of awaikening of 
about 90% and 75% to 80% probability of good outcome). Level 1a abnormalities (Table I) 
are still a relatively good sign too (69% of good outcome). These situations with preserved 
short latency SEP include brain oedema and/or diffuse axonal lesion without brainstem 
involvement. By contrast, level 2 or 3 abnormalities have been associated with death or 
vegetative states in more than 90% of cases, and with severe disability in almost 100%. 
Therefore, normal or absent cortical SEP are the strongest prognostic indicators, with an 
occurrence of about 70% in severly injured patients; 
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Level Description Remarks 
0 Normal  
1a 
Inter Peak Latency (IPL) increas without 
peak distorsion 
Drugs,metabolic 
disturbances,hypothermia,usually 
reversible 
1b 
Distorsion or disappearance,without proof 
of the integrity of the sensory receptors or 
proximal afferent pathways 
Uncertain pattern 
2 
Distorsion without disappearance, with 
proof of the integrity of the sensory system 
 
3 
Disappearance,with proof of the integrity 
of the sensory system 
 
Table 1. Classification of short-latency EP abnormalities 
3. The EEG 
The electroencephalogram (EEG) provides a non invasive way to dynamically assess brain 
function. Recent advances in computer technology, networking, and data storage have made 
continuous EEG (cEEG) monitoring practical, and its use is common in many Neuro 
Intensive Care Unit (NICU). Methods for analyzing and compressing the vast amounts of 
data generated by cEEG have allowed neurophysiologists to more efficiently review 
recordings from many patients monitored simultaneously and provide timely information 
for guiding treatment. There are still many hurdles in making monitoring of brain function 
truly real time, reliable, practical, and widely available, but the technology is progressing 
rapidly. The most common reason for performing cEEG is to detect nonconvulsive seizures 
(NCSzs) or non convulsive status epilepticus (NCSE). Although previously thought to be 
uncommon NCSzs and NCSE are being recognized more frequently. The current indications 
and potential uses for cEEG in the critically ill are summarized in Table II 
 
1.Detection of nonconvulsive seizures  
2.Detection of convulsive status epilepticus 
3.Stereotyped activity such as paroxysmal movements, nystagmus, twitching, jerking, 
hippus, autonomic variability 
4. Monitoring of ongoing therapy: 
 a)Induced coma for elevated intracranial pressure or refractory status 
 epilepticus 
 b) Assessing level of sedation 
5. Ischemia detection: 
 a)Vasospasm in subarachnoid hemorrhage 
 b)Cerebral ischemia in other patients at high risk for stroke 
6. Prognosis: 
 a)Following cardiac arrest 
 b)Following acute brain injury 
Table 2. Indications for Continuous Electroencephalogram (cEEG) Monitoring  
(Friedman D et al.2009) 
www.intechopen.com
 Brain Damage – Bridging Between Basic Research and Clinics 260 
NCSzs and NCSE are increasingly recognized as common occurrences in the ICU, where 
8%–48% of comatose patients may have NCSzs, depending on which patients are studied. 
NCSzs are electrographic seizures with little or no clinical manifestations, so EEG is 
necessary for detection. NCSE occurs when NCSzs are prolonged; a common definition is 
continuous or near-continuous electrographic seizures of at least 30 min duration. The 
most common manifestation is a depressed level of consciousness.Most patients with 
NCSzs have purely electrographic seizures, but other subtle signs can be associated with 
NCSzs, such as face and limb myoclonus, nystagmus, eye deviation, pupillary 
abnormalities (including hippus), and autonomic instability.None of these signs are 
highly specific for NCSz, and they are often seen under other circumstances in the 
critically ill patient; thus, cEEG is usually necessary to diagnose NCSzs. The etiologies for 
NCSzs and NCSE in ICU patients are similar to the causes of convulsive seizures in these 
patients. These include acute structural lesions, infections, metabolic derangements, 
toxins, withdrawal and epilepsy, all common diagnoses in the critically ill patient (Table 
III). However, NCSzs are the more common ictal manifestation in ICU patients and 
should be considered when evaluating the cause of or contributors to altered mental 
status, especially in high-risk populations.  
 
a)Primary criteria 
Any pattern lasting at least 10 s satisfying any one of the following three primary criteria: 
 -Repetitive generalized or focal spikes, sharp-waves, spike-and-wave complexes 
 at 3/s 
 -Repetitive generalized or focal spikes, sharp-waves, spike-and-wave or sharp-
 and-slow wave complexes at 3/s and the secondary criterion 
 -Sequential rhythmic, periodic, or quasi-periodic waves at _1/s and unequivocal 
 evolution in frequency (gradually increasing or decreasing by at least 1/s, e.g.  
 2–3/s), morphology, or location (gradual spread into or out of a region 
 involving at least two electrodes).  
 -Evolution in amplitude alone is not sufficient. Change in sharpness without 
 other change in morphology is not enough to satisfy evolution in morphology 
b)Secondary criterion 
Significant improvement in clinical state or appearance of previously absent normal 
electroencephalogram (EEG)-patterns (such as posterior-dominant “alpha” rhythm) 
temporally coupled to acute administration of a rapidly acting antiepileptic drug.  
Resolution of the “epileptiform” discharges leaving diffuse slowing without clinical 
improvement and without appearance of previously absent normal EEG patterns would 
not satisfy the secondary criterion. 
Adapted from Chong DJ, Hirsch LJ, J Clin Neurophysiol, 2005, 22, 79–91, who modified 
the criteria of Young et al.13 
Table 3. Criteria for Nonconvulsive Seizure (Chong DJ et al.,2005) 
4. Which patients are most likely to have nonconvulsive seizures? 
In our experience subarachnoid haemorrhage with severe vasospasm shows a higher 
incidence of epileptiform discharge 24-48 hours before detection of vasospasm Table IV 
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Study Study population 
EEG 
type 
Design N 
Percentage 
of patients 
with any 
seizures (%) 
Jordan Neuro ICU patients cEEG Retrospective 124 35 
De Lorenzo et al. prior convulsive SE cEEG Prospective 164 48 
Vespa et al. 
moderate to severe 
traumatic brain injury 
cEEG Prospective 94 22 
Vespa et al. 
stroke or intracerebral 
hemorrhage. 
cEEG Retrospective 109 19 
Claassen et al. 
decreased level of 
consciousness or 
suspected 
subclinical seizures. 
cEEG Retrospective 570 19 
Pandian et al. Neuro ICU patients cEEG Retrospective 105 68 
Jette 
Patients _18 yr old with 
suspected 
subclinical seizures. 
cEEG Retrospective 117 44 
Claassen et al. 
Patients with 
intracerebral 
hemorrhage 
cEEG Retrospective 102 31 
Oddo et al. 
suspected 
subclinical seizures 
cEEG Retrospective 201 27 
Bosco et al. 
Subarachnoid 
hemorrhage with severe 
vasospasm 
cEEG Retrospective 68 35 
Table 4. Studies Using Continuous Electroencephalogram (EEG) Monitoring in Critically Ill 
Patients for Detection of Nonconvulsive Seizures 
5. Cost-effectiveness 
Little information is available regarding the cost-effectiveness of cEEG monitoring. In part, 
this is due to the early stage of development of this technique. This also is related to rapid 
changes in the technology used to perform cEEG monitoring. Each year provides new 
capabilities, often at decreased overall cost, making timely assessment of cost-effectiveness 
difficult. Vespa PM et al.assessed available data from their monitoring experience at UCLA, 
and concluded that cEEG accounted for only 1% of hospital costs and, during its use, 
significantly affected critical decision making in >90% of 300 patients who underwent 
monitoring.They concluded, “cEEG is cost-effective and appears to offer additional quality 
to intensive care.” Claassen et al evaluating their experience in 15 patients undergo cEEG for 
evaluation of status epilepticus or nonconvulsive seizures associated with altered 
consciousness,determined that cEEG monitoring influenced clinical management—usually 
decisively—in 50 of 109 monitoring days. Assessing the cost-effectiveness of cEEG will, 
however, remain a difficult task. This is because the technology and capabilities continue to 
evolve rapidly, and because, given the clear diagnostic and therapy-guiding benefits evident 
to many patients undergoing monitoring, randomization of comatose and obtunded 
patients to receive or forego such monitoring may not be ethical. 
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6. Methods (from a personal experience of continuous EEG-SEP monitoring 
in Neurosurgical Intensive Care of Treviso Hospital Italy 2007-2009) 
Quantitative brain function monitor consisted of an EEG-SEP recording system located far 
from the patient bedside connected by a serial interface to a small amplification head box 
with 28 channels and a multimodal stimulator (NEMUS-EB Neuro, Italy) FIG 1. The 
acquired data were transmitted to the PC by means of optical fiber. This software allows the 
setting of cycles of SEP for each channel obtained to electrical stimulation of the right and 
left median nerve at the wrist. We used straight stainless steel needle electrodes. Stimulus 
intensity was set above motor threshold (15-20 mAmp), pulse duration was 0,2 ms; stimulus 
rate 3Hz. Electrodes were placed at Erb’s point (referred to posterior muscle), spinous 
process Cv7 (referred to anterior neck), P3 and P4 (referred both to Fz). Time base was 100 
ms; bandwidth 5 Hz-3KHz. An average of 200 responses were repeated and superimposed. 
The length of the SEP session was set through a user-defined macro. We used a recording 
macro of 12 minutes of EP every 50 minutes. EEG was recorded continuously. We recorded 
a first trace of EP as the template, to which the following traces were compared. We 
manually located the markers of the principal waves (N20 latency and N20-P25 amplitude), 
than we started the session. The software automatically recognize N20 and P25 peaks and 
puts the marker on the maximum negative and positive deflection within a narrow window 
of +1msec. Traces are displayed in cascades on one side of the screen, while the trends of 
SEP latencies and amplitude are displayed on the other side. A horizontal baseline 
represents latency and amplitude of the template; latency and/or amplitude modifications 
cause the lines diverge from baseline. Digital EEG is acquired through eight electrodes at the 
location F3,C3,T3,P3,F4,C4,T4,P4 of the International 10-20 System. These are referred to a 
reference electrode at midpoint between Fz and Cz. The needles were covered with a plastic 
transparent dressing. According to Amantini et al SEP of each side were graded on a 3-point 
scale as normal (N) if cortical complex N20/P25 amplitude and central conduction time 
(CCT) were normal (1,2 mcV=5° percentile); pathological (P) if CCT was prolonged and /or 
N20/P25 amplitude was<1,2mcV or the left-right amplitude asymmetry was greater than 
50%; absent (A) if cortical responses were absent with preserved N13. Taking into account 
responses in both hemispheres, 6 patterns were defined: NN, NP, PP, AN, AP and AA. We 
used an electroencephalographic classification for coma based on Synek modificated system 
(Synek VM ,1988). According to this, all the recordings were reviewed and classified, by a 
single expert EEGer in: 
 
 
IA-Delta/theta>50% reactivity, 
IB-Delta/theta>50% without reactivity, 
II-Triphasic waves, 
IIIA-Burst suppression with epileptiform activity, 
IIIB-Burst suppression without epileptiform activity, 
IV-Alpha/theta/spindle coma unreactive,  
VA-Epileptiform activity Generalized,  
VB-Epileptiform activity focal or multifocal, 
VIASuppression<20 mcV,but>10mcV, 
VIBsuppression< 10mcV. 
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A
B
C
 
Fig. 1. Example of continuous EEG–SEP monitoring setting in ICU 
A-Small amplification head-box with 28 channels and a multimodal stimulator  
(NEMUS-EB Neuro, Italy)The acquired data are transmitted to the PC by means of an 
optical fiber. 
B-We use straight stainless steel needle electrodes these are gathered in plaits of colored 
strings.The needles were covered with a plastic transparent dressing 
C-Plug-in to deconect the patient  
EEG traces were displayed on one side of the screen, and quantitative elettroencephalographic 
(QEEG) on the other side. QEEG consists of both frequency Color Spectral Density Array 
(CDSA) and amplitude (percentage of burst-suppression) analysis. The ICP was monitored 
with a an intraventricular catheter. ICP, CPP, Mean artery pressure (MAP) were stored in a 
database file. From these informations, the peak ICP level and the time of its occurrence were 
established for each patient during the monitoring period. In the SAH, Transcranial Doppler 
(TCD) was used for detecting vasospasm and guiding therapy. TCD monitoring by using 
bilateral 2 MHz Probes with probe holder were lasted at least 30 minutes per day through 
temporal windows and eye windows to explore the cerebral arteries flow. Vasospasm was 
diagnosed in the presence of TCD mean velocities above 120 cm/s (or a daily change in mean 
transcranial Doppler velocities of >50 cm/s) or angiographic arterial narrowing. Patients were 
treated with a standard protocol including intravenous muscle relaxants, mechanical 
ventilation, osmotic diuresis and cerebrospinal fluid (CSF) drainage for elevations in ICP>20-
25 mmHg. The respective lengths of EEG and SEP sessions were decided on the basis of 
clinical features. Monitoring went on until the monitorated parameters were stable and the 
patient was no more considered at risk of developing brain complications. Acquired data were 
saved on the recording remote PC used as a server. A follow up telephone interview was 
conducted at least 3 month after discharge from the hospital. The outcome was assessed using 
the 5 point Glasgow Outcome Scale (GOS,Jennet and Bond,1975). 
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7. Statistical analysis 
Our interest focused on assessing the degree to which level of SEP and EEG monitoring 
predicts GOS levels, in particular considering evolutions in time, independently from other 
concomitant variables. Hence, we fitted a model in which the ratio between probability that 
GOS shows a certain level and the probability to observe a lower level depends on levels 
and changes in SEP and EEG by taking into account the joint effect of other related 
variables. A proportional odds model (e.g. Agresti, 2002) has been fitted to data, by 
assuming, as reasonable first approximation, that the effect of each variable does not vary 
with the CGS score at admittance. We also fit a binary logistic model (e.g. Agresti, 2002) to 
estimate the effect of monitors on the probability of dying (GOS equal to 1). Both families of 
models, logistic and proportional odds, have been fitted by Maximum Likelihood and the 
partial effect of each variable has been tested by Likelihood Ratio test. 
8. Results  
A total of 68 patients (34 males and 34 females, mean age 53.19±14.44 years, range 18-83 
years) were monitored with continuous EEG-SEP for an average of 10+4 days and were 
included in the study. We observed that in all the patients who were clinically stable SEP 
never showed modification in latency or amplitude. On the contrary, whenever a 
neurological deterioration occurred with GCS decrease (in 20 patients, 29,4%) SEP always 
showed significant increase in latency and decrease in amplitude. In these 20 patients the 
EEG-SEP worsening was not correlated with an immediate increased ICP. In 16 out of 20 
patients EEG-SEP worsening appeared 24-48 hours before ICP rising. These patients had 
developed angiographic vasospasm with ischemic lesion at CT Scan. Moreover, EEG-SEP 
worsening appeared after ICP increase in 4 patients with brain swelling documented at a 
serial CT scan. In the first 16 patients, analysis of EEG showed nonconvulsive seizures with 
periodic discharges and rhythmic delta activity in a range of 48 hours before a documented 
TCD and angiographyc vasospasm. After EEG epileptiform discharge, SEP showed an 
instability of amplitude with increments and decrements upper 50% of baseline with a final 
reduction or dissapereance of cortical SEP (Fig II and Fig III). These patients documented 
cortical ischemia at a serial CT scan (TableV). 
 
 
No of 
patients 
SEP 
Stable 
Decrease 
SEP 
BEFORE 
ICP 
increase 
Decrease 
SEP 
AFTER 
ICP 
increase 
No of 
Vasospasm 
Epileptiform 
discharge(periodic 
discharges,rhythmic 
delta activity,spike-
wave or sharp-Wave) 
Increase 
ICP>25mmHg 
CTscan 
Secondary 
damage 
SAH 
51 
(75%) 
35 
(68,6%) 
16 (31,4%) 0 
16 
(31,4%) 
18 
(35,2%) 
27 
(52,9%) 
18 ischemic 
lesion 
ICH 
17 
(25%) 
13 
(76,5%) 
0 
4 
(23,5%) 
0 
6 
(40%) 
12 
(70,5%) 
12 mass 
effect 
tot 
68 
(100%) 
48 
(70,5%) 
16 
(23,5%) 
4 
(5,8%) 
18 
(26,4%) 
24 
(35,2%) 
39 
(57,3%) 
30 
(48,5%) 
Table 5. Temporal analysis of ICP and EEG worsening related to ICP increase, vasospasm 
and CT scan ischemic evidence. 
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Fig. 2. Multimodality monitoring for vasospasm after subarachnoid hemorrhage (SAH):  
SEP traces and trend, on right and with raw EEG and CDSA, on left. Angiographic 
vasospasm with ischemic lesion at CT Scan upper screen 
Fare clic per modificare lo stile del sottotitolo dello schema
 
Fig. 3. The EEG segment documents a nonconvulsive seizure discovered during an EEG 
performed to evaluate a 62-year-old women with subarhanoic hemorrhage Clinical seizure 
activity was not evident despite the repetitive occurrence of electrographic seizures. 
Continuous EEG monitoring was initiated to evaluate the effects of therapy. 
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In the table VI we show the p-values obtained by univariate association tests.  
 
Variable Association with GOS 
Association with 
mortality 
Age 0.637 0.363 
Duration 0.253 0.037 
Gender 0.488 0.183 
CGS-M < 0.001 < 0.001 
EEG initial  0.717 0.205 
EEG second  0.747 0.214 
EEG final 0.136 0.002 
SEP initial 0.001 0.514 
SEP second  0.002 0.152 
SEP final < 0.001 < 0.001 
EEG from first to second time 
interval (worsened) 
0.766 0.349 
EEG from second to third time 
interval (worsened) 
0.012 0.001 
EEG from first to third time interval 
(worsened) 
0.005 0.001 
SEP from first to second time 
interval (worsened) 
0.227 0.221 
SEP from second to third time 
interval (worsened) 
< 0.001 < 0.001 
SEP from first to third time interval 
(worsened) 
0.001 < 0.001 
Embolization 0.275 0.734 
Craniotomy 0.252 1 
Cr. Dec 0.407 0.215 
ICP 0.007 < 0.001 
Table 6. Univariate association measures: p-values 
We included in the logistic model all the available variables: age, sex, initial observed EEG 
and SEP levels, each of the dichotomised decrease of EEG and SEP level, ICP, available 
treatment and clinical variables during hospitalization, and extent of the observation time 
(table VII). Regarding ICP in particular, we divided patients accordingly to ICP major values 
during the monitoring time, and in particular accordingly to ICP values<20mmHg, 
20<ICP<40mmHg, and ICP>40mmHg. We selected the variables with a forward stepwise 
procedure by using the AIC criterion (Claeskens G et al). Note that differences between 
ICP< 20mmHg and 20<ICP<40mmHg were not significant (p>0,05), so the two classes were 
collapsed. The overall fit of this model is quite good, since goodness-of-fit of Chi Square 
statistics is 47.87 on 62 degrees of freedom, giving a p-value of 0.9. 
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Variable  Coefficient estimate  p-value  Odds  
Intercept  -6.1706  0.034  0.002 
Age  0.0914 0.040 1.096 
ICP >40 mmHg  6.5074 0.006 670.1 
Duration (days)  -0.5866 0.020 0.556 
EEG, from first to third time 
observation (worsened)  
3.1839 0.028 24.14 
SEP, from first to third time observation 
(worsened)  
3.4769 0.005 32.36 
Table 7. Summary of the final logistic model for the probability of GOS 1  
Considering the obtained estimates, when the EEG gets worse during the time of observation, 
the odds for dying increase of about 24% with respect to similar patients that did not get 
worse. SEP decrease is also significant: patients with worsening SEP show an odds-of-dying 
increase of about 32%. Moreover, the longer the duration of hospitalization, the lower the risk 
of dying. Each day of hospitalization decreases the odds of dying of about 50%. 
To assess whether the inclusion of EEG and SEP variations in the model improves 
prediction, we compared ROC curves of four models: the final model including both EEG 
and SEP variations, the two models obtained by removing either EEG or SEP variations, 
respectively, and the model fitted removing both EEG and SEP variations.  
The joint contribution of both variables was significant (p-value for comparisons between 
ROC curves is 0.046) even if each variable alone does not seem to be significant (p-
value=0.21 for eliminating from the final model EEG variation and p-value=0.15for 
eliminating SEP variation). 
Table VIII illustrates the coefficients and the p-values for the proportional odds model. As for 
the logistic model, we selected the most significant variables via a forward stepwise procedure 
considering the AIC index. Since very few patients showed GOS levels 2 and 5, we aggregated 
them to levels 3 and 4 respectively. Therefore, we obtained a three-level GOS. 
 
Variable  
Coefficient 
estimated  
p-value  exp(coefficient)  
Intercept 1|2  -1.799  <0.001  0.16  
Intercept 2|3  2.156  0.015  8.63  
CGS-M – worsened  -4.453  <0.001  0.01  
CGS-M – improved  2.660  0.004  14.29  
SEP, from first to second time 
observation (worsened)  
-2.807  0.002  0.06  
Table 8. Summary of the proportional odds model.  
Also this model has a good fit to data: Chi-square goodness-of-fit statistic is 85.86 on 131 
degrees of freedom, giving a p-value of almost 1. Here, only modifications of GCS-M and 
SEP during hospitalization are significant to predict the GOS level. Patients showing 
worsening SEP during the last time interval are less likely (1/20) to have a high GOS level 
than patients with stable SEP. Patients with a GCS-M getting worse during the entire 
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observational period have a probability of a high GOS level of 1%, if compared to patients 
with stable GCS-M. Moreover, an improved GCS-M increases the probability of a high GOS 
level of about 14 times (Table VII).  
We also tested a model excluding the GCS-M modifications in time. However, it did not fit as 
well, showing the importance of GCS-M changes during hospitalization. It is interesting to 
observe that the initial SEP level and its changes during hospitalization, the changes of EEG in 
the last period of observation, and the presence of ICP higher than 40 mmHg are significant 
variables when GCS-M is not considered, similarly to what we obtain with the logistic model.  
It is worth noting that demographic variables, like age and sex, are not significant in any of 
the models used to predict the GOS level. They were not significant even when considered 
alone (Table V). The treatments effect is not significant neither in association with the other 
variables, nor when considered alone (Table V).  
9. Discussion  
Continuous EEG-SEP is a relatively new, non-invasive, bedside monitoring tool that 
allows a functional measurement of neurological impairment. There are two main 
advantages of clinical neurophysiology with respect to clinical examination:it can be 
employed in sedated and/or curarized patients, and it provides quantitative data for 
comparison with follow up studies. Compressed presentations like cerebral function 
monitor (CFM) or CDSA may help visualize these long term changes that are due to 
variations in the level of sedation. These tools, should be carefully used with the 
collaboration of a competent neurophysiologist. It should be kept in mind that,like any 
other clinical or technical examination,clinical neurophysiology only evaluates the current 
functional brain status, so that any prognostic information needs to be updated in case of 
eventual complication. Moreover, SEP trend is based on two simple parameters, 
amplitude and latency. Amplitude decrease and latency increase are dependent on the 
physiopathology of brain damage. Amplitude is related to the number of fibers carrying 
the signal to the primary somatosensory cortex. In the central nervous system, latency is 
mainly associated to white matter swelling. In the peripheral nervous system, it is related 
to temperature and focal myelin dysfunctions. There is good evidence that serial evoked 
potential studies provide useful information about the functional recovery of impaired 
areas [Amantini A et al.2008, Moulton RJ et al. 1998]. This is particularly true during the 
early post-injury stage, as SEP are a sensitive measure of secondary damage. Our results 
clearly show that SEP frequently change over time. The SEP-EEG deterioration is 
probably related to many different pathogenetic mechanisms: In the case of ischemia 
following vasospasm, SEP modifications precede 24-48 hours ICP increasing (18 patients), 
in the case of brain oedema without hypoxic damage SEP modifications cames later (2 
patients) The most likely explanation for this temporal sequence of events is that 
uncontrollable ICP may simply be a sign of large volumes of non-viable brain in fatally 
injured patients [Moulton RJ et al 1998]. A continuous SEP monitoring has a strong 
prognostic power, because amplitude modifications usually precede clinical manifestation 
of functional integrity. As continuous SEP monitoring reveal the potential for recovery, it 
can sometimes direct the physician towards a more aggressive clinical management. SEP 
provide important information about patients who are pharmacologically paralyzed and 
sedated to help ventilation and ICP management. In this setting, we have frequently 
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relied on SEP measurement to direct the therapy. We discourage aggressive treatment 
(barbiturate coma, decompressive craniectomy) to control refractory ICP in patients who 
lost cortical SEP activity. Other investigators have also observed the absence of correlation 
between increased ICP and SEP deterioration. Focal injury results in primary damage to 
neurons and to the surrounding cerebral vessels. The secondary damage is due to 
ischemia and the cytotoxic cascade. Cytotoxic and vasogenic oedema in neurons leads to 
excitotoxic swelling. The SEP deterioration can have different timing, and it can occur 
before or after an ICP increase. Trends for ICP did not demonstrate a clear seizure-related 
effect on ICP or CPP in the hours directly before or during a seizure. The ICP always 
increased after vasospasm. Vasospasm is a primary source of neurologic co-morbidity 
after SAH. Trans-cranial Doppler ultrasounds (TCD) and cerebral angiography cannot be 
continuously performed; in contrast, EEG can constantly monitor the cerebral activity. In 
our series, the most sensitive QEEG monitoring parameter to detect seizures was CDSA. 
Seizures are often associated with transient increases in EEG power, although they have 
to be confirmed with the review of the raw EEG. Similarly, QEEG should never be 
interpreted without reviewing portions of the original waveforms. Most epileptiform 
activity occurred in the form of repetitive sharp waves. This activity shows a clear related 
predictive effect on vasospasm 24-48 hours in advance. QEEG data can be displayed with 
many methods [Jordan KG et al.1995, Rennie CJ et al 2002, Vespa PM et al. 1999]. CDSA 
depicts ictal and interictal data after a quantitative transformation of raw EEG data 
(Figure IV).  
 
 
Fig. 4. The spectrogram shows high frequency activity : non convulsive status epilepticus 
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Time is displayed on the x-axis. The upper graph is a colour spectrogram showing averaged 
root EEG power from 0 to 32 Hz (y-axis), created from consecutive 10-second EEG epochs 
(each composed of five 2-second windows) obtained from F3-C3, F4-C4. The patient’s 
repetitive seizures are now clear in the spectrogram as vertical bands of increased power. 
These graphs usually express power amplitude as a colour scale. Amplitude-integrated EEG 
graph can also provide a reasonable indication of the presence of suppression-burst activity. 
The somatosensory evoked potentials have not only a strong predictive power on outcome. 
They provide a feedback tool to modify and correct the treatment, according to the 
correlated neurological instability. If SEP are stable, the patient is neurologically stable even 
though ICP and CPP values are not in the normal range. Moreover, SEP can be pathological 
despite normal ICP and CPP values: in this case it is necessary to find the best ICP and CPP 
settings to re-establish “normal” evoked potentials values.  
10. Conclusions  
Our approach is based on the choice of an integrated EEG-SEP continuous monitoring,the 
respective parts of each test are individually evaluated,according to which one is likely to be 
more informative in these patients. SEP were always monitorable despite the frequent use of 
high level of neurosedation. As SEP monitoring shows high correlation with patient’s 
outcome, it defines a measurable level of initial damage basing on the template SEP 
baseline, and on measurable parameters like amplitude and latency. The temporal variation 
of these two parameters, evaluated with the continuous monitoring, can confirm whether 
the treatment is tailored to the neurological changes induced by the lesion responsible for 
the secondary damage. The findings from our experience show that SEP worsening is 
independently associated with a poor outcome in patients with coma after intracranial 
hemorrhage. It is measured by specific parameters that quantify the damage and it replaces 
the clinical data that are often not quantifiable due both to the patient sedation and to the 
subjective evaluation performed by the physician. The precocious SEP deterioration can 
detect neurological impairment earlier than other hemodynamic variables like ICP and CPP, 
allowing the improving of the treatment. However it is not always possible to block the 
pathophysiological process, despite its early identification. In patients with SAH, the early 
changes in SEP amplitude allow a timely detection of initial vasospasm. QEEG changes 
preceded clinical evidence of vasospasm. cEEG use has documented a surprisingly high 
incidence of nonconvulsive seizures and nonconvulsive status epilepticus in patients with 
acute cerebral ischemia and intracranial hemorrhages. The combined use of SEP and 
continuous EEG monitoring is a unique example of dynamic-brain-monitoring.  
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